ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,459.89
      0.93%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Invitae Corporation (NVTA)

      7. Invitae Corporation (NVTA) News

      NVTA

      Invitae (NVTA)

      Invitae Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:NVTA
      DateTimeSourceHeadlineSymbolCompany
      05/18/20234:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      05/18/20234:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      05/15/20234:07PMPR Newswire (US)Invitae to Appeal Trial VerdictNYSE:NVTAInvitae Corporation
      05/09/20234:46PMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:NVTAInvitae Corporation
      05/09/20234:13PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
      05/09/20234:01PMPR Newswire (US)Invitae Reports First Quarter 2023 Financial ResultsNYSE:NVTAInvitae Corporation
      05/01/20234:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      05/01/20234:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      05/01/20234:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      05/01/20234:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      04/26/20236:59AMPR Newswire (US)Invitae to Announce First Quarter 2023 Financial Results on Tuesday, May 9, 2023NYSE:NVTAInvitae Corporation
      04/24/20234:03PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NYSE:NVTAInvitae Corporation
      04/19/20234:28PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:NVTAInvitae Corporation
      04/19/20234:18PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:NVTAInvitae Corporation
      04/19/20234:16PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:NVTAInvitae Corporation
      04/17/20234:30PMPR Newswire (US)Invitae Publishes Annual Environmental, Social and Governance (ESG) ReportNYSE:NVTAInvitae Corporation
      04/13/20238:45AMPR Newswire (US)New Study Findings Published in Nature Show Circulating Tumor DNA (ctDNA) Can Predict and Detect Cancer Recurrence Earlier In Non-Small Cell Lung CancerNYSE:NVTAInvitae Corporation
      04/03/20234:32PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:NVTAInvitae Corporation
      03/22/20237:30AMPR Newswire (US)Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare DiseasesNYSE:NVTAInvitae Corporation
      03/21/20237:30AMPR Newswire (US)Invitae Announces Partnership with Epic to Streamline Genetic TestingNYSE:NVTAInvitae Corporation
      03/16/20237:30AMPR Newswire (US)Invitae Appoints Dr. W. Michael Korn as Chief Medical Officer for OncologyNYSE:NVTAInvitae Corporation
      03/15/20235:30PMPR Newswire (US)Invitae to Present Data at The American Clinical Genetics Meeting 2023 That Supports Removing Barriers to Genetic TestingNYSE:NVTAInvitae Corporation
      03/15/20234:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:NVTAInvitae Corporation
      03/14/20235:05PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
      03/08/20237:03AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
      03/06/20237:30AMPR Newswire (US)Invitae's PCM Assay for Minimal Residual Disease Receives its First Commercial CoverageNYSE:NVTAInvitae Corporation
      03/01/20234:05PMPR Newswire (US)Invitae to Present at the TD Cowen 43rd Annual Health Care ConferenceNYSE:NVTAInvitae Corporation
      03/01/20237:03AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:NVTAInvitae Corporation
      03/01/20236:52AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NYSE:NVTAInvitae Corporation
      03/01/20236:28AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NYSE:NVTAInvitae Corporation
       Showing the most relevant articles for your search:NYSE:NVTA